<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://ep.bmj.com">
<title>Archives of Disease in Childhood - Education and Practice current issue</title>
<link>http://ep.bmj.com</link>
<description>Archives of Disease in Childhood - Education and Practice RSS feed -- current issue</description>
<prism:eIssn>1743-0593</prism:eIssn>
<prism:coverDisplayDate>Jun  1 2013 12:00:00:000AM</prism:coverDisplayDate>
<prism:publicationName>Archives of Disease in Childhood - Education and Practice</prism:publicationName>
<prism:issn>1743-0585</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/98/3/81?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/98/3/82?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/98/3/84?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/98/3/91?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/98/3/92?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/98/3/93?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/98/3/99?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/98/3/106?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/98/3/108?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/98/3/113?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/98/3/119?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/98/3/120?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://hwmaint.ep.bmj.com/misc/home/ADC_95x60.gif" />
</channel>
<image rdf:about="http://hwmaint.ep.bmj.com/misc/home/ADC_95x60.gif">
<title>Archives of Disease in Childhood - Education and Practice</title>
<url>http://hwmaint.ep.bmj.com/misc/home/ADC_95x60.gif</url>
<link>http://ep.bmj.com</link>
</image>
<item rdf:about="http://ep.bmj.com/cgi/content/short/98/3/81?rss=1">
<title><![CDATA[Highlights from this issue]]></title>
<link>http://ep.bmj.com/cgi/content/short/98/3/81?rss=1</link>
<description><![CDATA[ <sec> <p>When I was a very new paediatric doctor I worked in a unit that routinely used steam to treat children who had croup. It was a fantastic treatment&mdash;you could tell that you were doing something seriously efficacious; you would open the cubicle door to review the child and walk into this thick humid atmosphere&mdash;you could almost hear the witches chanting &lsquo;Double, double toil and trouble; Fire burn, and caldron bubble&rsquo; in the distance. There was just one problem. It was rubbish. This was roundly demonstrated when new smoke detector systems were installed which were triggered by the steam, so we had to stop using it; it made absolutely no difference to the children we were treating. The evidence that steam was a waste of time was well established even by this time&mdash;plus the risks of directly or indirectly teaching parents insanities like &lsquo;boil a kettle in the corner...]]></description>
<dc:creator><![CDATA[Wacogne, I.]]></dc:creator>
<dc:date>2013-05-13T00:30:48-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2013-304275</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2013-304275</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Immunology (including allergy), Ear, nose and throat/otolaryngology, Medical humanities]]></dc:subject>
<dc:title><![CDATA[Highlights from this issue]]></dc:title>
<prism:publicationDate>2013-05-11</prism:publicationDate>
<prism:section>Epistle</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>81</prism:startingPage>
<prism:endingPage>81</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/98/3/82?rss=1">
<title><![CDATA[How to write a Problem Solving in Clinical Practice paper]]></title>
<link>http://ep.bmj.com/cgi/content/short/98/3/82?rss=1</link>
<description><![CDATA[
<p>An overview of the concept of problem solving in clinical practice, and how to go about writing an article to be submitted.</p>
]]></description>
<dc:creator><![CDATA[Skinner, G. J.]]></dc:creator>
<dc:date>2013-05-13T00:30:48-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303453</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2012-303453</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[How to write a Problem Solving in Clinical Practice paper]]></dc:title>
<prism:publicationDate>2013-05-11</prism:publicationDate>
<prism:section>Problem solving in clinical practice</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>82</prism:startingPage>
<prism:endingPage>83</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/98/3/84?rss=1">
<title><![CDATA[Outpatient respiratory management of the child with severe neurological impairment]]></title>
<link>http://ep.bmj.com/cgi/content/short/98/3/84?rss=1</link>
<description><![CDATA[
<p>Most paediatricians will have faced the challenge of managing respiratory problems in the child with severe neurological impairment. These children are under-represented in clinical trials, and data is therefore often extrapolated from other groups, for example children with cystic fibrosis. This means that robust evidence for respiratory management in children with severe neurological impairment is often lacking. Here we have attempted to piece together the existing evidence to provide a rational approach to the management of respiratory problems in children with severe neurological impairment. We also hope to highlight areas of uncertainty, in order to aid honest discussions with families. The respiratory management of the child with neuromuscular disease is beyond the scope of this article.</p>
]]></description>
<dc:creator><![CDATA[McCrea, N., O'Donnell, R., Brown, R.]]></dc:creator>
<dc:date>2013-05-13T00:30:48-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-302324</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2012-302324</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Pancreas and biliary tract, Drugs: CNS (not psychiatric), Neuromuscular disease, Child health, Cystic fibrosis]]></dc:subject>
<dc:title><![CDATA[Outpatient respiratory management of the child with severe neurological impairment]]></dc:title>
<prism:publicationDate>2013-05-11</prism:publicationDate>
<prism:section>Best practice</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>84</prism:startingPage>
<prism:endingPage>91</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/98/3/91?rss=1">
<title><![CDATA[Limbic encephalitis: a clinician's guide]]></title>
<link>http://ep.bmj.com/cgi/content/short/98/3/91?rss=1</link>
<description><![CDATA[ <sec> <p>Cases of limbic encephalitis are being increasingly recognised by paediatric neurologists. As they usually present initially to paediatricians it is vital they are aware of the presentation, important investigations and management (<cross-ref type="tbl" refid="EDPRACT2011301063TB1">table&nbsp;1</cross-ref>), as the prompt instigation of immunosuppression in the correct cases will prevent seizures and medial temporal lobe atrophy and significantly improve outcome. This is an excellent guide and includes some excellent MRI images with the various hippocamapl/temporal lobe changes.<cross-ref type="bib" refid="R1">1</cross-ref></p> <p>Key clinical features of limbic encephalitis:<l type="tab"><li><p> Cognitive, and particularly memory impairment</p> </li><li> <p> Temporal lobe seizures</p> </li><li> <p>MRI signal change within limbic structures, particularly in the hippocampus.</p> </li></l></p></sec> <p><fn><no>Competing interests</no><p>None.</p> </fn></p> <p><fn><no>Provenance and peer review</no><p>Commissioned; internally peer reviewed.</p> </fn></p> <p> <tbl id="EDPRACT2011301063TB1" loc="float"><no>Table 1</no><caption><p>An overview of investigation findings in some causes of limbic encephalitis</p> </caption><tblbdy top-stubs="1"><r><c cspan="1" rspan="1"></c><c cspan="1" rspan="1">Herpes simplex encephalitis</c><c cspan="1" rspan="1">Paraneoplastic limbic encephalitis</c><c cspan="1" rspan="1">vGKC limbic encephalitis</c><c cspan="1" rspan="1">Neuropil...]]></description>
<dc:creator><![CDATA[Bird-Lieberman, G. A.]]></dc:creator>
<dc:date>2013-05-13T00:30:48-07:00</dc:date>
<dc:identifier>info:doi/10.1136/edpract-2011-301063</dc:identifier>
<dc:identifier>hwp:master-id:edpract;edpract-2011-301063</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Journalology, Epilepsy and seizures, Infection (neurology), Child health, Competing interests (ethics)]]></dc:subject>
<dc:title><![CDATA[Limbic encephalitis: a clinician's guide]]></dc:title>
<prism:publicationDate>2013-05-11</prism:publicationDate>
<prism:section>What I have learnt from Practical Neurology</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>91</prism:startingPage>
<prism:endingPage>91</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/98/3/92?rss=1">
<title><![CDATA[Questions on adolescent articles]]></title>
<link>http://ep.bmj.com/cgi/content/short/98/3/92?rss=1</link>
<description><![CDATA[ <p>Welcome to the first of this new feature. Epilogue will appear regularly in <I>Education and Practice</I> and is intended to serve as means by which practising paediatricians can assess their own knowledge and skills. Some articles, as this one, will be based on articles already published in the journal. Others will be based on clinical cases, images or current practice guidelines.</p> <p>By successfully answering the questions, readers will be able to demonstrate to their own satisfaction that they have fully grasped the article, and thereby contribute to their own continuing professional development.</p> <p>Annotated answers will always be available in the same edition.</p> <p>The questions below are based on two articles which appeared in the June 2012 edition of <I>Education and Practice:</I></p> <p>Gleeson H, Turner G. Transition to adult services. <I>Arch Dis Child Educ Pract Ed</I> 2012;97:86&ndash;92. <A HREF="http://ep.bmj.com/content/97/3/86.full">http://ep.bmj.com/content/97/3/86.full</A></p> <p>White B, Viner RM. Improving communication with adolescents. <I>Arch Dis...]]></description>
<dc:creator><![CDATA[Scott-Jupp, R.]]></dc:creator>
<dc:date>2013-05-13T00:30:48-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2013-303842</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2013-303842</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Adolescent health, Child health, Confidentiality, Legal and forensic medicine, Medical humanities]]></dc:subject>
<dc:title><![CDATA[Questions on adolescent articles]]></dc:title>
<prism:publicationDate>2013-05-11</prism:publicationDate>
<prism:section>Epilogue</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>92</prism:startingPage>
<prism:endingPage>92</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/98/3/93?rss=1">
<title><![CDATA[How to use... neonatal TORCH testing]]></title>
<link>http://ep.bmj.com/cgi/content/short/98/3/93?rss=1</link>
<description><![CDATA[
<p>Toxoplasma gondii, rubella, cytomegalovirus and herpes simplex virus have in common that they can cause congenital (TORCH) infection, leading to fetal and neonatal morbidity and mortality. During the last decades, TORCH screening, which is generally considered to be single serum testing, has been increasingly used inappropriately and questions have been raised concerning the indications and cost-effectiveness of TORCH testing. The problems of TORCH screening lie in requesting the screening for the wrong indications, wrong interpretation of the single serum results and in case there is a good indication for diagnosis of congenital infection, sending in the wrong materials. This review provides an overview of the pathogenesis, epidemiology and clinical consequences of congenital TORCH infections and discusses the indications for, and interpretation of, TORCH screens.</p>
]]></description>
<dc:creator><![CDATA[de Jong, E. P., Vossen, A. C. T. M., Walther, F. J., Lopriore, E.]]></dc:creator>
<dc:date>2013-05-13T00:30:48-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303327</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2012-303327</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Travel medicine, Tropical medicine (infectious diseases), Screening (epidemiology), Screening (public health)]]></dc:subject>
<dc:title><![CDATA[How to use... neonatal TORCH testing]]></dc:title>
<prism:publicationDate>2013-05-11</prism:publicationDate>
<prism:section>Interpretations</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>93</prism:startingPage>
<prism:endingPage>98</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/98/3/99?rss=1">
<title><![CDATA[How to use: interferon {gamma} release assays for tuberculosis]]></title>
<link>http://ep.bmj.com/cgi/content/short/98/3/99?rss=1</link>
<description><![CDATA[
<p>Diagnosis and treatment of latent tuberculosis infection (LTBI) is important to reduce risk of progression to active tuberculosis (TB) disease. For the past century the tuberculin skin test (TST) has been used as a measure of exposure to Mycobacterium tuberculosis (MTB), but this test has limitations in test performance, sensitivity and specificity. Interferon  release assays (IGRA), like TST, measure host immune response to MTB. IGRA are designed to be more specific for the diagnosis of LTBI than TST in patients with previous BCG or exposure to non-tuberculous mycobacteria, detecting interferon  generated by T cells in response to antigens more specific to MTB. Although developed as an alternative to TST, recent data, particularly in children, suggest IGRA have their own limitations. Superiority to TST as a diagnostic test in children has not been demonstrated. Neither test discriminates between current or past MTB infection, or between latent infection and active disease. This article reviews the current literature on sensitivity and specificity of IGRA in the diagnosis of LTBI, and summarises current NICE recommendations for the use of IGRA in combination with TST. Although not developed for this purpose, in clinical practice IGRA have also been used as a diagnostic test for active TB. The gold standard for diagnosis of active TB disease is microbiological confirmation by culture of MTB. This article discusses the utility of IGRA as an adjunct to diagnosis of active TB disease, but emphasises that IGRA do not have sufficient sensitivity or specificity to exclude or confirm active TB disease.</p>
]]></description>
<dc:creator><![CDATA[Pollock, L., Basu Roy, R., Kampmann, B.]]></dc:creator>
<dc:date>2013-05-13T00:30:48-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2013-303641</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2013-303641</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Immunology (including allergy), Child health, Clinical diagnostic tests]]></dc:subject>
<dc:title><![CDATA[How to use: interferon {gamma} release assays for tuberculosis]]></dc:title>
<prism:publicationDate>2013-05-11</prism:publicationDate>
<prism:section>Interpretations</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>99</prism:startingPage>
<prism:endingPage>105</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/98/3/106?rss=1">
<title><![CDATA[Alopecias]]></title>
<link>http://ep.bmj.com/cgi/content/short/98/3/106?rss=1</link>
<description><![CDATA[ <p><b><I>Answers to the following quiz questions can be found on <addart type="iti" doi="10.1136/archdischild-2012-303256a">page 120</addart></I></b>.</p> <sec id="s2"><st>Question 1</st> <p><I>Case 1</I>: An otherwise healthy 6-month-old boy presents with several patches of alopecia, slowly increasing in size over the past month. He is noted to have two school-aged brothers at home. On examination, there is an erythematous, boggy mass on the scalp with associated alopecia and occipital lymphadenopathy (<cross-ref type="fig" refid="EDPRACT2012303256F1">figure 1</cross-ref>). What is the most likely diagnosis?</p> </sec> <sec id="s3"><st>Question 2</st> <p><I>Case 2</I>: A healthy 9-year-old girl presents with an enlarging patch of alopecia on the posterior scalp for 5&nbsp;months. It is asymptomatic, and she denies any pustules or pruritus. The child is very upset by the hair loss but is otherwise healthy. On physical examination, there is a large patch of alopecia with fairly well-defined borders on the posterior scalp (<cross-ref type="fig" refid="EDPRACT2012303256F2">figure 2</cross-ref>). Close examination reveals &lsquo;exclamation point hairs&rsquo;:...]]></description>
<dc:creator><![CDATA[Lio, P. A., Lee, K. C.]]></dc:creator>
<dc:date>2013-05-13T00:30:48-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303256</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2012-303256</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Immunology (including allergy), Child health, Disability, Dermatology, Ear, nose and throat/otolaryngology]]></dc:subject>
<dc:title><![CDATA[Alopecias]]></dc:title>
<prism:publicationDate>2013-05-11</prism:publicationDate>
<prism:section>Dermatophile</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>106</prism:startingPage>
<prism:endingPage>107</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/98/3/108?rss=1">
<title><![CDATA[Pharmacological management of obese child]]></title>
<link>http://ep.bmj.com/cgi/content/short/98/3/108?rss=1</link>
<description><![CDATA[
<p>Childhood overweight and obesity are increasingly common management problems for clinicians. This review focuses on the pharmacological management of obesity in children. It considers historical treatments, the options currently available (principally orlistat and metformin) and some potential future therapeutic interventions. The short term psychological effect of obesity and longer term health impact are discussed. The clinical settings in which drug treatment may be appropriate, the importance of lifestyle interventions, and the evidence and clinical guidance that underpin their use are discussed.</p>
]]></description>
<dc:creator><![CDATA[Petkar, R., Wright, N.]]></dc:creator>
<dc:date>2013-05-13T00:30:48-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301127</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2011-301127</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Obesity (nutrition), Child health, Health education, Obesity (public health), Health promotion]]></dc:subject>
<dc:title><![CDATA[Pharmacological management of obese child]]></dc:title>
<prism:publicationDate>2013-05-11</prism:publicationDate>
<prism:section>Pharmacy update</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>108</prism:startingPage>
<prism:endingPage>112</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/98/3/113?rss=1">
<title><![CDATA[Bronchodilators in wheezy under 2-year-olds: when and which (if any)?]]></title>
<link>http://ep.bmj.com/cgi/content/short/98/3/113?rss=1</link>
<description><![CDATA[ <sec id="s1"><st>Clinical case</st> <p>Amy is 13&nbsp;months old and presented to the children's emergency department with a 5-week history of wheezing. Her parents explain that they have seen her general practitioner twice and attended the local walk-in centre three times over the last month. She has been prescribed antibiotics and salbutamol both of which Amy &lsquo;hates&rsquo;. On examination, she had a dry cough with mild respiratory distress. She has occasional crepitations and widespread wheeze. Parents smoke &lsquo;outside the house&rsquo; but neither has asthma. She is their first child. Clinically, she is well but parents would like to know whether inhalers will help.</p> </sec> <sec id="s2"><st>Introduction</st> <p>Birth cohort studies have demonstrated that approximately one-third of the children aged between 1 and 5&nbsp;years suffer recurrent episodes of respiratory symptoms including wheeze. Wheezing prevalence in UK children has increased from twofold to threefold during the past 40&nbsp;years but may have stabilised or even...]]></description>
<dc:creator><![CDATA[Carroll, W. D., Srinivas, J.]]></dc:creator>
<dc:date>2013-05-13T00:30:48-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303078</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2012-303078</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Editor's choice, Immunology (including allergy), Drugs: infectious diseases, Child health, Airway biology, Asthma, Drugs: respiratory system]]></dc:subject>
<dc:title><![CDATA[Bronchodilators in wheezy under 2-year-olds: when and which (if any)?]]></dc:title>
<prism:publicationDate>2013-05-11</prism:publicationDate>
<prism:section>Pharmacy update</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>113</prism:startingPage>
<prism:endingPage>118</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/98/3/119?rss=1">
<title><![CDATA[Answers to Epilogue questions]]></title>
<link>http://ep.bmj.com/cgi/content/short/98/3/119?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p><I>From questions on <addart type="iti" doi="10.1136/archdischild-2013-303842">page 92</addart></I>.</p> </sec> <sec id="s2"><st>Answers to question 1</st> <p>2004&mdash;Standard 4 in the National Service Framework for Children, Young People and Maternity Services (Department of Health, 2004)</p> <p>2006&mdash;Transition: Getting it Right for Young People (Department of Health, 2006)</p> <p>2007&mdash;Aiming High for Disabled Children (AHDC): Better Support for Families (Department for Education, 2007) and A Transition Guide for All Services: Key Information for Professionals about the Transition Process for Disabled Children (Department of Health, 2007)</p> <p>2007&mdash;You're Welcome quality criteria (Department of Health, 2007)</p> <p>2008&mdash;Transition: Moving on Well (Department of Health, 2008)</p> </sec> <sec id="s3"><st>Answers to question 2</st> <p>Fidelity, confidentiality, competency, honesty, a global perspective, non-judgemental approach, continuity</p> </sec> <sec id="s4"><st>Answers to question 3</st> <p>Level 3: Complex needs (5%)</p> <p>Care requires health and social care system to work together. This calls for case management, with a key worker actively managing and joining up care for...]]></description>
<dc:creator><![CDATA[Scott-Jupp, R.]]></dc:creator>
<dc:date>2013-05-13T00:30:48-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2013-303842a</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2013-303842a</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Health informatics, Journalology, Competing interests (ethics), Confidentiality, Legal and forensic medicine]]></dc:subject>
<dc:title><![CDATA[Answers to Epilogue questions]]></dc:title>
<prism:publicationDate>2013-05-11</prism:publicationDate>
<prism:section>Epilogue</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>119</prism:startingPage>
<prism:endingPage>119</prism:endingPage>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/98/3/120?rss=1">
<title><![CDATA[Answers to Dermatophile questions]]></title>
<link>http://ep.bmj.com/cgi/content/short/98/3/120?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p><I>From questions on <addart type="iti" doi="10.1136/archdischild-2012-303256">page 106</addart></I>.</p> </sec> <sec id="s2"><st>ANSWER TO Question 1</st> <p>The answer is (D), kerion. This is a manifestation of tinea capitis, ringworm of the scalp. It can occur in more severe cases and in the very young, resulting in a boggy mass on the scalp with loss of hair. Diagnosis can be difficult as potassium hydroxide preparations can be negative in the presence of such inflammation; culture is frequently needed to prove scalp infection. Treatment must be in the form of an oral antifungal drug &nbsp;indicated for tinea capitis for sufficient duration. Use of a topical antifungal shampoo is recommended concurrently to decrease spread of the disease.<cross-ref type="bib" refid="R1">1</cross-ref></p> </sec> <sec id="s1a2"><st>ANSWER TO Question 2</st> <p>The answer is (A), alopecia areata. Alopecia areata is a common, usually patchy and often unpredictable hair loss on the scalp and the body, thought to be primarily...]]></description>
<dc:creator><![CDATA[Lio, P. A., Lee, K. C.]]></dc:creator>
<dc:date>2013-05-13T00:30:48-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-303256a</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2012-303256a</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Journalology, Immunology (including allergy), Drugs: infectious diseases, Child health, Dermatology, Competing interests (ethics), Thyroid disease]]></dc:subject>
<dc:title><![CDATA[Answers to Dermatophile questions]]></dc:title>
<prism:publicationDate>2013-05-11</prism:publicationDate>
<prism:section>Dermatophile</prism:section>
<prism:volume>98</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>120</prism:startingPage>
<prism:endingPage>120</prism:endingPage>
</item>
</rdf:RDF>